Please ensure Javascript is enabled for purposes of website accessibility
Thrombosis & Haemostasis Society of Australia and New Zealand
Login
Login

Thrombosis & Haemostasis society of Australia and New Zealand

Promote Excellence in clinical care for people with clotting and bleeding disorders.
Our Story

Education & Training

Lead education and training for scientists and clinicians in the field
Find Training

Clinical Research

Foster innovation through research, discovery and clinical trials
View Research

Policy & Advocacy

Advocate and develop policies that improve health outcomes
View Resources

About THANZ

Our story

The THANZ was founded following discussions amongst coagulation enthusiasts led by Beng Chong, who had met together for the 1993 annual HSA meeting in Hobart. Until that time, clotters had consoled themselves within a loose association or "club" and the membership of this club was automatically inherited by THANZ...
Read more

Member Benefits

MEMBER-OnLY Events
Network and learn form clinicians and researchers who are pioneering the industry
Member-only Resources
Access information and resources via our members-only web portal 
Regular Newsletters
Stay up to date with regular news updates delivered directly to your inbox
Access to a community
Access to a highly active and qualified community of professional
Find out more

Upcoming Events & Workshops

Latest news

Use of the new 4-factor PCC, Beriplex

  • March 18th, 2025
As of mid-2024, Australia’s prothrombin complex concentrate (PCC) has been replaced by the new 4-factor PCC (Factors II, VII, IX, X) BERIPLEX P/N (international plasma).  From February 2025, the...
Read more

2024 S&E Travel Grants Awarded

  • July 30th, 2024
This year THANZ awarded 6 S&E Travel Grants to the following members, who travelled to ISTH, Bangkok  Rowena Brook, Emma Leitinger, Mitchell Moon, Caitlin Rice, Mark Schreuder and Trish Wise ...
Read more

2024 S&E Research Grants Awarded

  • July 30th, 2024
This year THANZ awarded S&E Research Grants to the following members mma Leitinger (Monash Health, Vic)Comparability of anti-Xa assessments using alternate calibration curves in patients...
Read more

IVIg use for Heparin induced thrombocytopenia (HIT) and Vaccine induced thrombotic thrombocytopenia (VITT)

  • February 29th, 2024
The National Blood Authority (NBA) has approved the inclusion of 5 indications of Heparin induced thrombocytopenia (HIT) in the Criteria for the clinical use of immunoglobulin in Australia (the C...
Read more

National COVID-19 Clinical Evidence Taskforce Guidelines

  • December 20th, 2023
The COVID-19 Vaccine Claims Scheme is being extended The COVID-19 Vaccine Claims Scheme is due to close on 17 April 2024. However, following the Mid-Year Economic and Fiscal Outlook (MYEFO) update pub...
Read more

ARES Study published

  • November 1st, 2023

The THANZ Anticoagulation Reversal and Events Study (ARES) Collaborative has recently published the results of the ARES Study. The paper is available here

Read more
View all
Our Sponsors

2024 Corporate Sponsor

THANZ receives financial assistance from the following corporate supporter
Support us
© 2025
 Thrombosis & Haemostasis Society of Australia and New Zealand
Created with Heartburst